Daiwa Securities Group Inc. Has $3.51 Million Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Daiwa Securities Group Inc. boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 3.6% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 31,811 shares of the medical device company’s stock after buying an additional 1,102 shares during the period. Daiwa Securities Group Inc.’s holdings in Cooper Companies were worth $3,510,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of COO. Ashton Thomas Securities LLC bought a new position in shares of Cooper Companies in the 3rd quarter valued at $25,000. Innealta Capital LLC acquired a new stake in Cooper Companies in the second quarter valued at about $25,000. Covestor Ltd grew its position in Cooper Companies by 144.9% in the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after acquiring an additional 200 shares during the last quarter. Crewe Advisors LLC raised its stake in Cooper Companies by 286.4% during the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock worth $30,000 after acquiring an additional 252 shares in the last quarter. Finally, Tortoise Investment Management LLC lifted its holdings in shares of Cooper Companies by 75.4% in the second quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock worth $34,000 after acquiring an additional 169 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on COO. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Wednesday. Stifel Nicolaus reiterated a “buy” rating and set a $115.00 price target (up from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Wells Fargo & Company raised their price objective on Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a report on Thursday, August 29th. Morgan Stanley upped their target price on Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a report on Tuesday, September 10th. Finally, Piper Sandler increased their target price on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Four analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat.com, Cooper Companies currently has an average rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Price Performance

Cooper Companies stock opened at $103.43 on Thursday. The firm has a market cap of $20.60 billion, a P/E ratio of 57.62, a P/E/G ratio of 2.21 and a beta of 0.99. The stock’s 50 day moving average is $105.59 and its 200 day moving average is $98.45. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.18. The Cooper Companies, Inc. has a one year low of $82.21 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The firm had revenue of $1 billion for the quarter, compared to the consensus estimate of $997.30 million. During the same quarter in the previous year, the company earned $0.84 EPS. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. As a group, research analysts expect that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Insider Activity at Cooper Companies

In other news, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the sale, the chief executive officer now owns 165,273 shares in the company, valued at $18,267,624.69. The trade was a 41.03 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Brian G. Andrews sold 24,788 shares of the stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the transaction, the chief financial officer now directly owns 6,614 shares in the company, valued at approximately $700,422.60. This represents a 78.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 256,373 shares of company stock worth $27,637,427 over the last quarter. Company insiders own 2.00% of the company’s stock.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.